Ten years on, Facebook remains an important channel through which pharma can engage with patients. What has been learned in that time and how have communication strategies evolved within the... Read more
Andrew McConaghie reports on contrasting views on 2014's merger and acquisition rollercoaster ride, and the forces propelling it.
The annual pharma / biotech sector conference hosted by the Financial Times usually yields... Read more
AstraZeneca (AZ) predicted yesterday that its "industry-leading" cancer portfolio would account for a quarter of its revenues in 2023 and is now considered its sixth growth platform.Just six months ago... Read more
Novartis' Cosentyx (secukinumab) is the first IL-17A inhibitor to receive a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) as a first-line... Read more
New research from the Association of the British Pharmaceutical Industry (ABPI) shows that 90 per cent of clinicians and other health professionals surveyed believe that stratified medicine will positively impact... Read more
While every pharma company recognises the potential of multichannel marketing to optimize its engagement with prescribers, many are yet to implement it to maximum potential. IMS Health explains how a... View info